Global Suprapubic Catheter Market - 2022-2029

Global Suprapubic Catheter Market - 2022-2029

Market Overview

Suprapubic Catheter Market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 6.8% during the forecast period (2022-2029).

A Suprapubic Catheter (SPC) is a device inserted into the bladder to drain urine or remove unwanted fluid waste. SPCs are usually more suitable than regular catheters as they are not inserted through the urethra, which is full of sensitive tissue. An SPC is inserted a couple of inches below the navel directly into the bladder, just above pubic bone, which permits urine to be drained without a tube going through the genital area.

Market Dynamics

Technological advancements, the rising prevalence of bladder cancer, the growing geriatric population, the increasing number of patients with urinary incontinence and product launches drive the global suprapubic market.

The increasing prevalence of bladder cancer drives the market growth

Due to the increase in the majority of urologic diseases, the major players are developing treatment devices with advanced technology, leading to the growth of the suprapubic catheter market worldwide.

Cancer of the bladder, known as urological or urinary bladder cancer, is the 10th most familiar cancer in the world. Its incidence is continually advancing worldwide, particularly in developed nations such as the United States. According to the article in Medical Sciences, in 2020, bladder cancer was over four times more typical in men than women, with an incidence of 9.6/100,000 among men and 2.4/100,000 globally.

The major risk factor for bladder cancer is tobacco smoking, which accounts for 50–65% of all cases. Occupational or environmental toxins contribute greatly to disease burden (accounting for an estimated 20% of all cases). However, the precise proportion can be covered by the fact that bladder cancer develops decades after exposure, even if the exposure only lasts several years. Schistosomiasis infection is the familiar cause of bladder cancer in Africa and the Middle East region and is considered the second most onerous tropical pathogen after malaria. With 81% of cases attributable to known risk factors (and only 7% to heritable mutations), bladder cancer is a prime candidate for prevention strategies. The increasing prevalence of bladder cancer leads to increasing demand for suprapubic catheters worldwide.

The side effects of suprapubic catheter will hamper the growth of the market

However, suprapubic catheter-related small bowel injury or obstruction is a unique complication of a common urologic procedure. The most serious rare complications associated with suprapubic catheters are bowel perforation and obstruction. These factors are limiting the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global suprapubic market. As per the article published in the African Journal of Urology, in July 2021, there was a decrease of 93.86% in indoor admissions of urology patients during the COVID-19 lockdown. Indoor admissions for stone disease, haematuria, and malignancy accounted for 53.65%, 15.85%, and 9.75%, respectively. Elective surgeries had the highest percentage decline, followed by emergency and semi-emergency procedures. There was a decrease of more than 80% in patients attending outpatient clinics. Stone disease and its effects were the major reasons for seeing outdoor clinics (39%). A significant number of patients showed flank and abdominal pain (14.8%) and benign prostate enlargement (10.23%). Malignancy accounted for a very small number of patients visiting outdoor clinics (1.58%).

In addition, an increased prevalence of urological complications due to agitation and delirium correlated with COVID-19. A significant increase in bladder and suprapubic catheter self-extractions was observed among hospitalized COVID-19 patients.

In 2022, the COVID-19 situation is recovering, and all patients can access healthcare facilities, leading to the growing suprapubic market worldwide.

Segment Analysis

The free drainage catheters segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The free drainage catheters segment accounts for the largest market share. Free drainage is where the urine drains out from the catheter and is generally stored in a drainage bag. As per the article published in StatPearls, in 2021, suprapubic catheterization refers to placing a drainage tube into the urinary bladder just above the pubic symphysis. This is typically performed for individuals unable to drain their bladder via the urethra.

Suprapubic catheterization offers an alternative to drain the urinary bladder when other techniques are not clinically possible, unpleasant or incomprehensible. Equipment used for the placement of a suprapubic catheter varies by technique. Generally, standard Foley catheters are used for drainage catheters. The open technique employs standard surgical instrumentation, including a small self-retaining retractor such as a Weitlander retractor and a dissolvable suture for closure of the cystostomy.

Rising patients with conditions such as urinary incontinence, urinary retention, surgery on the prostate or genitals, and other medical conditions such as multiple sclerosis, spinal cord injury, or dementia increase the demand for free drainage catheters in the market.

Geographical Analysis

North America region holds the largest market share of the global suprapubic market

North America dominates the market for suprapubic and is anticipated to show a similar trend over the forecast period. The market in this North America is growing due to several factors, such as the rising number of urology patients, increasing healthcare infrastructure, and technological advancement in the devices by major players. In addition, an increasing number of various diseases, such as bladder cancer, cardiovascular, neurological, and gastrointestinal, in this region is leading to an increase in the demand for suprapubic catheters.

According to The American Cancer Society’s report for bladder cancer in the U.S. for 2022 are approximately 81,180 new cases of bladder cancer, close to 61,700 in men and 19,480 in women. Nearly 17,100 deaths from bladder cancer, about 12,120 in men and 4,980 in women.

In the U.S., bladder cancer is the sixth most incidence neoplasm. 90% of bladder cancer diagnoses are made in those 55 and older, and the disease is four times more common in men than women. While the average 5-year survival in the U.S. is 77%, the 5-year survival for those with metastatic disease is a measly 5%. Increasing cases of bladder cancer drive the suprapubic market in the North American region.

Competitive Landscape

The suprapubic market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are B. Braun Medical Inc., Amecath, MacGregor Healthcare Ltd, Cook Medical, Teleflex Inc., Fortune Medical Instrument Corp., Degania Silicon Ltd., Bard Medical, Urovision GmbH, and UroTech Inc., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the suprapubic market globally.

For instance,
• In March 2021, a UK firm's suprapubic catheter system was adopted by Texas radiologists. Utilizing the Seldinger Technique, the S-Cath System offers several advantages to both the clinical staff and the patient, such as greater control, accuracy, and reduced risk of trauma and tissue damage for the patient.

B. Braun SE

Overview:

B. Braun provides smart infusion therapy and safe and effective pharmacy products; founded in 1839 and headquartered in the Germany. The company develops effective solutions and guiding standards for the healthcare system in a constructive dialogue with customers and partners.

Product Portfolio:

Cystofix Punction Set: The Cystofix punction set with a preassembled catheter within the cannula is ready to use catheter set for suprapubic percutaneous urine catheterization. The Certon catheter assures a high drainage flow. The features include a preassembled catheter within the cannula to facilitate and shorten the preparation procedure reducing the risk of sharp injury.

The global suprapubic market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200 (approximate) pages.